chr8-142229492-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_145003.5(TSNARE1):c.1534C>T(p.Arg512Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00133 in 1,614,044 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0071 ( 11 hom., cov: 32)
Exomes 𝑓: 0.00073 ( 12 hom. )
Consequence
TSNARE1
NM_145003.5 stop_gained
NM_145003.5 stop_gained
Scores
1
6
Clinical Significance
Conservation
PhyloP100: -0.0300
Genes affected
TSNARE1 (HGNC:26437): (t-SNARE domain containing 1) Predicted to enable SNAP receptor activity and SNARE binding activity. Predicted to be involved in intracellular protein transport; vesicle docking; and vesicle fusion. Predicted to be located in membrane. Predicted to be part of SNARE complex. Predicted to be active in endomembrane system. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 8-142229492-G-A is Benign according to our data. Variant chr8-142229492-G-A is described in ClinVar as [Benign]. Clinvar id is 716150.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00709 (1080/152230) while in subpopulation AFR AF= 0.0244 (1014/41520). AF 95% confidence interval is 0.0232. There are 11 homozygotes in gnomad4. There are 499 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 11 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TSNARE1 | NM_145003.5 | c.1534C>T | p.Arg512Ter | stop_gained | 13/14 | ENST00000524325.6 | |
TSNARE1 | NM_001363740.2 | c.1537C>T | p.Arg513Ter | stop_gained | 13/14 | ||
TSNARE1 | NM_001366901.1 | c.1531C>T | p.Arg511Ter | stop_gained | 13/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TSNARE1 | ENST00000524325.6 | c.1534C>T | p.Arg512Ter | stop_gained | 13/14 | 2 | NM_145003.5 | A2 | |
TSNARE1 | ENST00000520166.5 | c.1537C>T | p.Arg513Ter | stop_gained | 12/13 | 1 | P2 | ||
TSNARE1 | ENST00000307180.4 | c.1537C>T | p.Arg513Ter | stop_gained | 13/14 | 5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00707 AC: 1076AN: 152112Hom.: 11 Cov.: 32
GnomAD3 genomes
AF:
AC:
1076
AN:
152112
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00190 AC: 479AN: 251454Hom.: 3 AF XY: 0.00150 AC XY: 204AN XY: 135904
GnomAD3 exomes
AF:
AC:
479
AN:
251454
Hom.:
AF XY:
AC XY:
204
AN XY:
135904
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000733 AC: 1071AN: 1461814Hom.: 12 Cov.: 32 AF XY: 0.000642 AC XY: 467AN XY: 727214
GnomAD4 exome
AF:
AC:
1071
AN:
1461814
Hom.:
Cov.:
32
AF XY:
AC XY:
467
AN XY:
727214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00709 AC: 1080AN: 152230Hom.: 11 Cov.: 32 AF XY: 0.00670 AC XY: 499AN XY: 74440
GnomAD4 genome
AF:
AC:
1080
AN:
152230
Hom.:
Cov.:
32
AF XY:
AC XY:
499
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
114
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
304
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
N;N;N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at